BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -14.25% -19.94% -13.65% -9.84% -9.84% -14.06% -3.57% -1.96% 13.98% 04/07/2010
BIB NAV -14.45% -20.03% -13.70% -10.00% -10.00% -14.09% -3.57% -1.97% 13.97% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 1/29/2025
  • NAV
    $54.99
  • NAV Change
    $-0.29 down caret
  • Market Price
    $54.82
  • Market Price Change
    $-0.55 down caret
  • Trading Volume (M)
    7,101
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 1/29/2025
  • NAV
    $54.99
  • NAV Change
    $-0.29 down caret
  • Market Price
    $54.82
  • Market Price Change
    $-0.55 down caret
  • Trading Volume (M)
    7,101
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 12/31/2024

Holdings

as of 1/29/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.38% GILD GILEAD SCIENCES INC -- $4,142,297.06 43,334 2369174
6.16% AMGN AMGEN INC -- $3,995,630.80 14,185 2023607
5.83% VRTX VERTEX PHARMACEUTICALS INC -- $3,783,826.40 8,570 2931034
5.31% REGN REGENERON PHARMACEUTICALS -- $3,443,222.70 5,010 2730190
2.92% AZN ASTRAZENECA PLC-SPONS ADR -- $1,897,241.75 27,007 2989044
2.53% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,639,008.18 5,982 B00FWN1
1.51% ARGX ARGENX SE - ADR -- $978,211.44 1,494 BDVLM39
1.50% BIIB BIOGEN INC -- $975,345.14 6,754 2455965
1.49% ILMN ILLUMINA INC -- $968,537.16 7,353 2613990
1.19% UTHR UNITED THERAPEUTICS CORP -- $771,965.25 2,071 2430412
1.14% SMMT SUMMIT THERAPEUTICS INC -- $739,979.80 34,195 BMTVQS7
1.12% SNY SANOFI-ADR -- $728,118.30 13,962 2964557
1.12% MRNA MODERNA INC -- $726,770.56 17,848 BGSXTS3
1.09% NBIX NEUROCRINE BIOSCIENCES INC -- $707,593.28 4,696 2623911
1.01% INCY INCYTE CORP -- $658,540.76 8,933 2471950
1.01% RPRX ROYALTY PHARMA PLC- CL A -- $658,138.05 20,599 BMVP7Y0
1.00% INSM INSMED INC -- $647,088.00 8,296 2614487
0.97% VTRS VIATRIS INC -- $627,070.18 55,346 BMWS3X9
0.96% ITCI INTRA-CELLULAR THERAPIES INC -- $624,176.28 4,914 BHCB0P4
0.86% BMRN BIOMARIN PHARMACEUTICAL INC -- $560,796.02 8,837 2437071
0.85% BNTX BIONTECH SE-ADR -- $551,762.64 4,554 BK6H543
0.79% PCVX VAXCYTE INC -- $512,512.60 5,780 BKPVGH6
0.79% SRPT SAREPTA THERAPEUTICS INC -- $511,328.05 4,429 B8DPDT7
0.76% MEDP MEDPACE HOLDINGS INC -- $494,634.84 1,442 BDCBC61
0.72% ONC BEIGENE LTD-ADR -- $466,115.76 2,056 BYYWPW6
0.67% EXEL EXELIXIS INC -- $436,456.32 13,242 2576941
0.58% ROIV ROIVANT SCIENCES LTD -- $375,693.15 33,755 BMW4NZ9
0.55% -- TEMPUS AI INC COMMON STOCK USD 0.0001 -- $358,842.36 7,068 --
0.55% ASND ASCENDIS PHARMA A/S - ADR -- $356,757.35 2,797 BV9G6B8
0.54% JAZZ JAZZ PHARMACEUTICALS PLC -- $348,453.08 2,804 B4Q5ZN4
0.52% BPMC BLUEPRINT MEDICINES CORP -- $336,558.08 2,944 BWY52P3
0.51% MDGL MADRIGAL PHARMACEUTICALS INC -- $330,245.96 1,012 BD59BS7
0.51% HALO HALOZYME THERAPEUTICS INC -- $329,508.66 5,902 2975098
0.49% BBIO BRIDGEBIO PHARMA INC -- $319,535.44 8,764 BK1KWG8
0.49% RVMD REVOLUTION MEDICINES INC -- $319,094.16 7,798 BL71K91
0.42% GH GUARDANT HEALTH INC -- $272,891.55 5,727 BFXC911
0.41% CYTK CYTOKINETICS INC -- $266,164.15 5,471 BBBSBJ5
0.40% NUVL NUVALENT INC-A -- $260,066.32 3,041 BMVBZD3
0.37% IONS IONIS PHARMACEUTICALS INC -- $240,747.36 7,322 BDJ0LS6
0.36% ALKS ALKERMES PLC -- $236,794.68 7,503 B3P6D26
0.36% AXSM AXSOME THERAPEUTICS INC -- $236,249.58 2,247 BYZR4X4
0.32% KRYS KRYSTAL BIOTECH INC -- $208,504.20 1,334 BD6JX35
0.29% VRNA VERONA PHARMA PLC - ADR -- $188,066.90 3,430 BYWPZK5
0.29% SRRK SCHOLAR ROCK HOLDING CORP -- $185,136.00 4,350 BFZQ0L8
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $181,899.01 4,283 BJ62Z18
0.28% ADMA ADMA BIOLOGICS INC -- $179,524.80 10,960 B9NSBM2
0.27% RNA AVIDITY BIOSCIENCES INC -- $176,645.28 5,534 BMWHPY1
0.27% AKRO AKERO THERAPEUTICS INC -- $174,744.00 3,236 BK7Y2V9
0.26% APLS APELLIS PHARMACEUTICALS INC -- $169,982.96 5,768 BYTQ6X1
0.26% CRNX CRINETICS PHARMACEUTICALS IN -- $169,334.00 4,300 BDD19F8
0.25% CRSP CRISPR THERAPEUTICS AG -- $163,067.97 3,957 BDHF4K6
0.25% RYTM RHYTHM PHARMACEUTICALS INC -- $162,877.12 2,848 BF2YWG4
0.25% ACLX ARCELLX INC -- $161,902.06 2,507 BPCJ1Q2
0.25% PTCT PTC THERAPEUTICS INC -- $161,706.72 3,576 B17VCN9
0.25% VCYT VERACYTE INC -- $159,628.48 3,592 BFTWZY0
0.24% DNLI DENALI THERAPEUTICS INC -- $156,214.93 6,673 BD2B4V0
0.24% -- ALVOTECH SA COMMON STOCK USD 0.0001 -- $155,528.61 12,373 --
0.23% IMVT IMMUNOVANT INC -- $148,346.32 6,808 BJRFSB7
0.22% XENE XENON PHARMACEUTICALS INC -- $142,111.84 3,536 BRJ3GY4
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $141,669.44 7,712 2713317
0.21% LEGN LEGEND BIOTECH CORP-ADR -- $136,710.70 3,787 BMX9K07
0.21% TWST TWIST BIOSCIENCE CORP -- $136,180.00 2,750 BGKG6G7
0.21% VCEL VERICEL CORP -- $135,005.22 2,289 BSBMN89
0.20% FOLD AMICUS THERAPEUTICS INC -- $132,859.86 13,854 B19FQ48
0.20% MRUS MERUS NV -- $132,280.40 3,176 BZBY005
0.20% NVCR NOVOCURE LTD -- $128,008.32 5,016 BYSS4X4
0.20% RXRX RECURSION PHARMACEUTICALS-A -- $126,753.48 17,703 BM9FJ13
0.19% SWTX SPRINGWORKS THERAPEUTICS INC -- $125,994.00 3,450 BGMGM89
0.19% AMRX AMNEAL PHARMACEUTICALS INC -- $125,441.37 14,369 BFNF1D6
0.19% EWTX EDGEWISE THERAPEUTICS INC -- $124,763.80 4,390 BKY5JZ8
0.18% KYMR KYMERA THERAPEUTICS INC -- $118,397.00 3,005 BMPRZV5
0.18% ARWR ARROWHEAD PHARMACEUTICALS IN -- $115,111.50 5,770 BYQBFJ8
0.17% VERA VERA THERAPEUTICS INC -- $111,286.62 2,934 BL55460
0.17% MIRM MIRUM PHARMACEUTICALS INC -- $108,135.00 2,225 BJDX8Y8
0.16% PTGX PROTAGONIST THERAPEUTICS INC -- $105,536.02 2,762 BDCBCD8
0.16% LGND LIGAND PHARMACEUTICALS -- $104,173.92 876 2501578
0.16% JANX JANUX THERAPEUTICS INC -- $103,469.34 2,434 BMFX8Y7
0.16% HRMY HARMONY BIOSCIENCES HOLDINGS -- $102,717.72 2,646 BKSGZN7
0.16% IBRX IMMUNITYBIO INC -- $102,109.08 32,313 BNSP0B8
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $99,879.00 2,561 B72ZBG4
0.15% BEAM BEAM THERAPEUTICS INC -- $99,468.49 3,839 BK6L288
0.15% IDYA IDEAYA BIOSCIENCES INC -- $95,975.46 4,009 BK0VHF6
0.15% CGON CG ONCOLOGY INC -- $94,959.15 3,135 BRBCSP4
0.14% TARS TARSUS PHARMACEUTICALS INC -- $94,040.04 1,772 BMH5RL1
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $89,249.58 2,646 BCBVTX1
0.14% -- NEWAMSTERDAM PHARMA CO NV COMMON STOCK USD -- $89,000.74 4,283 --
0.13% IOVA IOVANCE BIOTHERAPEUTICS INC -- $85,781.24 14,132 BF0DMK7
0.13% GPCR STRUCTURE THERAPEUTICS INC -- $84,900.75 2,761 BQS9486
0.13% WVE WAVE LIFE SCIENCES LTD -- $84,251.34 7,074 BYZG9R0
0.13% APGE APOGEE THERAPEUTICS INC -- $84,228.48 2,089 BM9HHL5
0.13% TVTX TRAVERE THERAPEUTICS INC -- $81,411.45 3,981 BLFGJD5
0.13% AMPH AMPHASTAR PHARMACEUTICALS IN -- $81,180.18 2,229 BNFWZS4
0.12% GERN GERON CORP -- $81,009.59 28,031 2370381
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $79,087.14 6,093 BRJZSK0
0.12% MNKD MANNKIND CORP -- $77,957.49 12,759 BF081J4
0.12% IRON DISC MEDICINE INC -- $77,114.40 1,380 BMGJZJ8
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $77,024.08 9,604 2100362
0.12% -- INDIVIOR PLC COMMON STOCK USD 0.5 -- $76,812.30 6,322 --
0.11% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $74,485.88 5,429 BKX9VD3
0.11% TXG 10X GENOMICS INC-CLASS A -- $73,636.08 4,962 BKS3RS7
0.11% CNTA CENTESSA PHARMACEUTICALS-ADR -- $70,146.56 4,136 BLB0YQ9
0.11% VIR VIR BIOTECHNOLOGY INC -- $69,596.50 6,385 BK4PZ38
0.11% FTRE FORTREA HOLDINGS INC -- $68,623.50 4,159 BRXYZ57
0.10% ZLAB ZAI LAB LTD-ADR -- $65,866.32 2,418 BD9GVY0
0.10% NVAX NOVAVAX INC -- $65,528.78 7,438 BJDQXG4
0.10% NRIX NURIX THERAPEUTICS INC -- $64,589.55 3,287 BMVLGP2
0.10% SPRY ARS PHARMACEUTICALS INC -- $64,540.24 4,507 BMCR7V2
0.10% PRAX PRAXIS PRECISION MEDICINES I -- $63,953.28 864 BQ721R4
0.10% DYN DYNE THERAPEUTICS INC -- $63,895.26 4,719 BN15WD1
0.09% XNCR XENCOR INC -- $61,103.35 3,245 BGCYWN8
0.09% DAWN DAY ONE BIOPHARMACEUTICALS I -- $60,834.76 4,676 BLB0YH0
0.09% ARDX ARDELYX INC -- $60,181.36 10,982 BN89V40
0.09% SYRE SPYRE THERAPEUTICS INC -- $59,611.80 2,722 BQBBDY8
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $58,091.04 1,836 BLCD809
0.09% ANIP ANI PHARMACEUTICALS INC -- $57,866.25 975 BCDWBX6
0.09% OCUL OCULAR THERAPEUTIX INC -- $57,153.60 7,290 BNZB1X8
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $56,347.68 3,957 BN7Q7R7
0.09% ARVN ARVINAS INC -- $55,949.40 3,188 BDZ30Q0
0.09% PCRX PACIRA BIOSCIENCES INC -- $55,704.20 2,140 B3X26D8
0.08% INVA INNOVIVA INC -- $54,856.56 2,904 BDDXF67
0.08% AUPH AURINIA PHARMACEUTICALS INC -- $54,041.46 6,639 BFWLC09
0.08% HROW HARROW INC -- $53,442.20 1,652 BHNDW86
0.08% ADPT ADAPTIVE BIOTECHNOLOGIES -- $52,751.82 6,842 BJ5FZ74
0.08% REPL REPLIMUNE GROUP INC -- $50,201.76 3,568 BDDVW37
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $48,435.48 1,494 BX7RSN3
0.07% NTLA INTELLIA THERAPEUTICS INC -- $47,796.76 4,723 BYZM6C2
0.07% COGT COGENT BIOSCIENCES INC -- $47,634.60 5,122 BLR6XK8
0.07% ETNB 89BIO INC -- $47,604.69 5,453 BK1K484
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $47,289.62 2,267 BMFD115
0.07% ZYME ZYMEWORKS INC -- $46,693.56 3,196 BPCQZY9
0.07% AVBP ARRIVENT BIOPHARMA INC -- $45,358.26 1,563 BMGTLY5
0.07% RCKT ROCKET PHARMACEUTICALS INC -- $44,003.07 4,227 BDFKQ07
0.07% ABCL ABCELLERA BIOLOGICS INC -- $43,827.20 13,696 BL53SR3
0.07% EOLS EVOLUS INC -- $42,719.04 2,934 BDRJH21
0.06% GRAL GRAIL INC -- $41,544.07 1,558 BSLSSX7
0.06% CVAC CUREVAC NV -- $40,259.61 10,403 BN4RD42
0.06% KNSA KINIKSA PHARMACEUTICALS INTE -- $39,832.48 1,928 BRXB0C0
0.06% GRFS GRIFOLS SA-ADR -- $39,592.00 5,656 B8K7T65
0.06% PRTA PROTHENA CORP PLC -- $39,430.14 2,494 B91XRN2
0.06% GMAB GENMAB A/S -SP ADR -- $38,568.55 1,943 BBC9WC7
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $38,130.70 3,931 BYTYP72
0.06% ORIC ORIC PHARMACEUTICALS INC -- $36,493.95 3,273 BKVDFF7
0.06% CSTL CASTLE BIOSCIENCES INC -- $35,737.00 1,300 BKLCWZ3
0.05% RLAY RELAY THERAPEUTICS INC -- $34,778.24 7,763 BN2R582
0.05% QURE UNIQURE NV -- $34,457.64 2,261 BJFSR88
0.05% TYRA TYRA BIOSCIENCES INC -- $34,383.55 2,347 BMVNDH9
0.05% AVDL AVADEL PHARMACEUTICALS -- $34,217.22 4,467 BDGMC59
0.05% SANA SANA BIOTECHNOLOGY INC -- $33,647.25 10,353 BMFJJ97
0.05% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $33,077.28 6,576 BMCWKZ2
0.05% LENZ LENZ THERAPEUTICS INC -- $32,104.50 1,275 BQV0J03
0.05% CRMD CORMEDIX INC -- $31,781.35 2,815 BJ0LT31
0.05% CGEM CULLINAN THERAPEUTICS INC -- $30,375.00 2,700 BM90J52
0.05% PLRX PLIANT THERAPEUTICS INC -- $30,319.02 2,823 BMDWW66
0.05% VERV VERVE THERAPEUTICS INC -- $30,222.50 3,925 BNKGXX2
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $29,706.82 8,789 BZ0QMB7
0.04% -- MESOBLAST LTD ADR USD -- $28,992.65 1,483 --
0.04% CRGX CARGO THERAPEUTICS INC -- $28,134.27 2,133 BQHN2F2
0.04% KURA KURA ONCOLOGY INC -- $27,722.45 3,605 BYZD465
0.04% IRWD IRONWOOD PHARMACEUTICALS INC -- $27,606.12 7,421 B3MZ6K5
0.04% HUMA HUMACYTE INC -- $27,209.52 5,967 BMYTJP4
0.04% RAPP RAPPORT THERAPEUTICS INC -- $26,508.48 1,696 BR3T9B6
0.04% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $26,466.22 2,039 BKDQKM6
0.04% STOK STOKE THERAPEUTICS INC -- $25,833.58 2,458 BJQ05Z6
0.04% XERS XERIS BIOPHARMA HOLDINGS INC -- $25,228.80 6,912 BLR7H87
0.04% MNMD MIND MEDICINE MINDMED INC -- $24,880.68 3,399 BPQYY97
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $24,736.00 3,200 BMGS7L1
0.04% ANAB ANAPTYSBIO INC -- $24,562.20 1,410 BDRW1L7
0.04% ERAS ERASCA INC -- $24,124.24 13,111 BNLYBF3
0.04% MLYS MINERALYS THERAPEUTICS INC -- $23,973.04 2,314 BP9N0G0
0.04% OMER OMEROS CORP -- $23,287.62 2,686 B4NB858
0.04% TRDA ENTRADA THERAPEUTICS INC -- $22,992.84 1,734 BP81RK8
0.04% ALT ALTIMMUNE INC -- $22,921.10 3,298 BFY7DC4
0.03% MXCT MAXCYTE INC -- $22,694.24 4,891 BKMQF66
0.03% TKNO ALPHA TEKNOVA INC -- $22,668.24 2,472 BP7L561
0.03% RNAC CARTESIAN THERAPEUTICS INC -- $22,652.94 1,178 BQB9HM8
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $22,523.16 3,624 BFYQFJ2
0.03% TBPH THERAVANCE BIOPHARMA INC -- $21,956.40 2,280 BMNDK09
0.03% URGN UROGEN PHARMA LTD -- $21,535.56 1,956 BZ7PJQ1
0.03% KROS KEROS THERAPEUTICS INC -- $21,352.86 1,878 BM7V485
0.03% SVRA SAVARA INC -- $21,247.86 7,958 BYXGN81
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $21,134.20 1,255 BKC9SX3
0.03% SAGE SAGE THERAPEUTICS INC -- $20,809.87 2,839 BP4GNK9
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $20,770.05 3,171 BJLKVS6
0.03% SIGA SIGA TECHNOLOGIES INC -- $20,714.34 3,309 2107437
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $20,695.50 945 BL95N25
0.03% ANNX ANNEXON INC -- $20,361.04 4,942 BMVV9R5
0.03% ABSI ABSCI CORP -- $19,919.24 5,326 BN94K69
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $19,820.20 2,260 BD06CS0
0.03% AUTL AUTOLUS THERAPEUTICS PLC -- $19,812.12 9,258 BFMLGR4
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $19,807.32 12,697 B4N8MH9
0.03% HCM HUTCHMED CHINA-ADR -- $19,627.96 1,439 BYXV9H7
0.03% -- ORUKA THERAPEUTICS INC COMMON STOCK USD 0.001 -- $19,601.68 1,624 --
0.03% ATXS ASTRIA THERAPEUTICS INC -- $19,522.82 2,617 BMYRFN8
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $19,461.36 2,476 BLFBZ32
0.03% TRML TOURMALINE BIO INC -- $19,416.37 1,189 BQ80NC6
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $18,374.33 817 BQD3J33
0.03% AURA AURA BIOSCIENCES INC -- $18,334.80 2,315 BP81R42
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $17,886.64 9,721 BFZNYB7
0.03% OABI OMNIAB INC -- $17,793.21 5,613 BN13S71
0.03% RVNC REVANCE THERAPEUTICS INC -- $17,737.72 4,873 BJFSR99
0.03% PGEN PRECIGEN INC -- $17,652.70 13,579 BKM5C84
0.03% -- TECTONIC THERAPEUTIC INC COMMON STOCK USD 0.0001 -- $17,592.48 684 --
0.03% RGNX REGENXBIO INC -- $17,280.96 2,298 BZ0G875
0.03% ESPR ESPERION THERAPEUTICS INC -- $17,270.82 9,138 BBNBTD2
0.03% GLUE MONTE ROSA THERAPEUTICS INC -- $17,053.53 2,847 BP7KZP7
0.03% CDXS CODEXIS INC -- $16,860.84 3,772 B5LL2C2
0.03% PRME PRIME MEDICINE INC -- $16,731.00 6,084 BPBJFM7
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $16,499.97 2,657 BMZ4LN0
0.03% TERN TERNS PHARMACEUTICALS INC -- $16,460.84 3,938 BMDJ0C9
0.03% PSNL PERSONALIS INC -- $16,417.77 3,277 BJQ0608
0.02% TNGX TANGO THERAPEUTICS INC -- $15,490.91 4,981 BP2P6L0
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $15,138.40 2,980 BYP80F1
0.02% GLPG GALAPAGOS NV-SPON ADR -- $15,014.16 648 B292NQ7
0.02% NMRA NEUMORA THERAPEUTICS INC -- $14,457.63 7,491 BN4JN37
0.02% ALMS ALUMIS INC -- $14,300.70 2,190 BPLQG36
0.02% TSHA TAYSHA GENE THERAPIES INC -- $14,257.50 9,505 BNC1BX1
0.02% VYGR VOYAGER THERAPEUTICS INC -- $13,987.68 2,534 BY7RB53
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $13,833.68 16,762 BWFZX59
0.02% TRVI TREVI THERAPEUTICS INC -- $13,753.18 3,563 BJH9ZN0
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $13,106.80 4,228 BYVQJ96
0.02% DSGN DESIGN THERAPEUTICS INC -- $12,972.44 2,626 BMFK3H6
0.02% YMAB Y-MABS THERAPEUTICS INC -- $12,779.70 2,078 BG31GH0
0.02% ITOS ITEOS THERAPEUTICS INC -- $12,688.06 1,694 BMWXFT4
0.02% VNDA VANDA PHARMACEUTICALS INC -- $12,249.12 2,704 B12W3P6
0.02% ACIU AC IMMUNE SA -- $12,107.04 4,586 BZC0D70
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $11,771.10 8,118 BPG5P75
0.02% AVIR ATEA PHARMACEUTICALS INC -- $11,754.00 3,918 BLN9Z50
0.02% CCCC C4 THERAPEUTICS INC -- $11,753.66 3,274 BKX9NQ0
0.02% -- SILENCE THERAPEUTICS PLC ADR USD 0.05 -- $11,423.20 2,180 --
0.02% AMLX AMYLYX PHARMACEUTICALS INC -- $11,002.80 3,180 BPCK358
0.02% LRMR LARIMAR THERAPEUTICS INC -- $10,974.18 2,958 BMXNGZ6
0.02% THRD THIRD HARMONIC BIO INC -- $10,873.20 2,091 BNNPQY8
0.02% FDMT 4D MOLECULAR THERAPEUTICS IN -- $10,705.00 2,141 BKLXFX5
0.02% NGNE NEUROGENE INC -- $10,686.39 689 BS2F741
0.02% AMRN AMARIN CORP PLC -ADR -- $10,485.27 18,558 2301938
0.02% FHTX FOGHORN THERAPEUTICS INC -- $10,252.48 2,576 BMF7DT9
0.01% CMPS COMPASS PATHWAYS PLC -- $9,648.31 2,359 BMC3HS7
0.01% SLRN ACELYRIN INC -- $8,883.41 4,651 BQPF874
0.01% MGNX MACROGENICS INC -- $8,823.36 2,912 BFDV8K0
0.01% INBX INHIBRX BIOSCIENCES INC -- $8,284.63 673 BNSP8K3
0.01% LXEO LEXEO THERAPEUTICS INC -- $8,080.71 1,551 BQ6C357
0.01% ACRV ACRIVON THERAPEUTICS INC -- $8,008.65 1,443 BP2TPK4
0.01% SCPH SCPHARMACEUTICALS INC -- $7,629.51 2,319 BYX2Z16
0.01% LYEL LYELL IMMUNOPHARMA INC -- $7,506.09 12,946 BN6MB18
0.01% ALEC ALECTOR INC -- $7,448.88 4,542 BJ4LDC4
0.01% NKTX NKARTA INC -- $7,331.52 3,273 BK80YJ8
0.01% STRO SUTRO BIOPHARMA INC -- $7,191.00 3,825 BF12XC2
0.01% BMEA BIOMEA FUSION INC -- $7,085.38 1,679 BNKF6N0
0.01% FATE FATE THERAPEUTICS INC -- $6,992.78 5,338 BCZS820
0.01% KYTX KYVERNA THERAPEUTICS INC -- $6,483.24 2,001 BSMLR16
0.01% SLDB SOLID BIOSCIENCES INC -- $6,163.83 1,851 BQHN6C7
0.01% ARTV ARTIVA BIOTHERAPEUTICS INC -- $6,068.64 1,128 BMF1LJ7
0.01% CLYM CLIMB BIO INC -- $6,011.95 3,115 BMW5LX6
0.01% TSVT 2SEVENTY BIO INC -- $5,951.10 2,390 BMTXV88
0.01% TCRX TSCAN THERAPEUTICS INC -- $5,695.00 2,278 BNLYBJ7
0.01% EDIT EDITAS MEDICINE INC -- $5,130.86 3,829 BZ8FPH3
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $4,890.36 982 B9L5200
0.01% PYXS PYXIS ONCOLOGY INC -- $4,242.70 2,755 BLBR8D5
0.01% INZY INOZYME PHARMA INC -- $4,230.18 2,979 BMVLGY1
0.01% MRSN MERSANA THERAPEUTICS INC -- $3,361.16 5,726 BF3NP05
-- OKUR ONKURE THERAPEUTICS INC-A -- $3,131.04 593 BT7KGT6
-- APLT APPLIED THERAPEUTICS INC -- $2,938.66 5,395 BJL38Z1
-- PEPG PEPGEN INC -- $2,780.24 1,511 BMTX3D7
-- IGMS IGM BIOSCIENCES INC -- $2,321.13 1,579 BKS3SM8
-- QTTB Q32 BIO INC -- $1,822.52 566 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
39.06% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 25,345,719 -- 5,622 --
35.43% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 22,992,381 -- 5,100 --
24.32% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 15,779,085 -- 3,500 --
9.18% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,955,478 -- 1,321 --
6.61% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,287,403 -- 951 --
6.60% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 4,282,895 -- 950 --
4.75% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 3,079,176 -- 683 --
-- -- TREASURY BILL -- $9,928,528.30 10,000,000 BTBKBR5
-- -- NET OTHER ASSETS (LIABILITIES) -- $6,559,825.37 6,559,825 --

Index

as of 12/31/2024

  • Total Number of Companies265
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.58 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.